期刊文献+

血清NGAL和Cys-C对老年冠心病患者早期肾损害的诊断价值 被引量:9

Diagnostic value of serum NGAL and Cys-C for early renal damage in aged patients with chronic heart failure of coronary heart disease
下载PDF
导出
摘要 目的:探讨老年冠心病患者血清中性粒细胞明胶酶相关脂质运载蛋白(NGAL)和胱抑素 C (Cys-C)水平与心肾功能关系及其对早期肾损害的诊断价值。方法:选择84例老年冠心病患者,NYHA心功能Ⅰ~Ⅳ级(Ⅰ级组30例、II级组28例、Ⅲ~Ⅳ级组26例),另选择31例老年健康者为健康对照组。测定患者血清 N末端 B型利钠肽原(NT-proBNP)、NGAL和Cys-C等指标,并分析血清 NGAL和 Cys-C水平与 NT-proBNP和估计肾小球滤过率(eGFR)的相关性。应用受试者操作工作特征(ROC)曲线评价血清 NGAL和Cys-C诊断肾功能不全的准确性。结果:健康对照组,NYHAⅠ、II、Ⅲ~Ⅳ级组血清 NGAL [(36.96±21.23)μg/L比(87.80±61.40)μg/L比(141.21±92.96)μg/L比(198.15±98.46)μg/L]和Cys-C [(0.75±0.64)mg/L比(1.40±1.88)mg/L比(2.33±2.03)mg/L比(3.45±1.81)mg/L]水平随着心衰程度加重而升高,以 NYHAⅢ~Ⅳ级组升高最为明显,4组血清 NGAL水平两两比较均有显著性差异(P<0.01),而血清 Cys-C水平除在 NYHAI级组与健康对照组比较无显著性差异(P>0.05)外,其余各组两两比较差异均有统计学意义(P<0.05或<0.01)。Pearson相关分析显示血清 NGAL和Cys-C水平与 NT-proBNP均呈正相关(r值分别为0.842和0.718,P均<0.01),与 eGFR均呈负相关(r值分别为-0.689和-0.448,P均<0.01),且血清NGAL水平与NT-proBNP和eGFR的相关性更密切。血清 NGAL和Cys-C诊断肾功能不全的 ROC曲线下面积分别为0.884和0.744。结论:老年冠心病慢性心力衰竭患者血清 NGAL和Cys-C水平与心肾功能有较好的相关性,是诊断早期肾损害敏感而准确的指标。 Objective:To explore the relationship among serum neutrophil gelatinase associated lipocalin (NGAL), cystatin C (Cys-C) levels and cardiac, renal function;and diagnostic value of NGAL and Cys-C for early renal damage in aged patients With coronary heart disease (CHD).Methods:According to NYHA cardiac function classi-fication,a total of 84 aged CHD patients Were divided into class I group (n=30),class Ⅱ group (n=28)and classⅢ-Ⅳ group (n=26).Another 31 aged healthy objects Were selected as healthy control group.Serum N terminal pro B-type natriuretic peptide (NT-proBNP),NGAL and Cys-C etc. levels Were measured,and the correlation a-mong serum NGAL,Cys-C levels and cardiac function,estimated glomerular filtration rate (eGFR)Were analyzed. The accuracy of serum NGAL and Cys-C diagnosing renal insufficiency Was evaluated by receiver operator character-istic curve (ROC).Results:Along With NYHA class increased,there Were significant increase in serum levels of NGAL [(36.96±21.23)μg/L vs.(87.80±61.40)μg/L vs.(141.21±92.96)μg/L vs.(198.15±98.46)μg/L] and Cys-C [(0.75±0.64)mg/L vs.(1.40±1.88)mg/L vs.(2.33±2.03)mg/L vs.(3.45±1.81)mg/L]in healthy control group,NYHA I,Ⅱ,Ⅲ-Ⅳ groups,and they Were highest in NYHA class Ⅲ-Ⅳ group,there Was significant difference in serum NGAL level betWeen any tWo groups among the four groups (P〈0.01),and so Was serum Cys-C level (P〈0.05 or 〈0.01)except healthy control group and NYHA class I group (P〉0.05). Pearson correlation analysis indicated that serum NGAL and Cys-C levels Were positively correlated With NT-proBNP (r=0.842,0.718,P〈0.01 both),and negatively correlated With eGFR (r=-0.689,-0.448,P〈0.01 both), and serum NGAL level had closer correlation With NT-proBNP and eGFR.Area under ROC of serum NGAL and Cys-C Were 0.884 and 0.744 respectively in diagnosing renal insufficiency.Conclusion:Serum NGAL and Cys-C lev-els have good correlation With cardiac and renal function in aged CHD patients,Which are sensitive and accurate in-dexes for diagnosing early renal damage.
出处 《心血管康复医学杂志》 CAS 2014年第2期170-175,共6页 Chinese Journal of Cardiovascular Rehabilitation Medicine
基金 卫生部行业科研专项项目基金(201002011) 北京市保健科研课题项目基金(京11-13号)~~
关键词 载体蛋白质类 半胱氨酸蛋白酶抑制剂 心力衰竭 充血性 Carrier proteins Cysteine proteinase inhibitors Heart failure,congestive
  • 相关文献

参考文献17

  • 1Hillege HL, Nitsch D, Pfeffer MA, et al. Renal function as a predictor of outcome in a broad spectrum of patients with heart failure [J]. Circulation, 2006, 113 (5): 671-678.
  • 2Scrutinio D, Passantino A, Lagioia R, et al. Detection and prog nostic impact of renal dysfunction in patients with chronic heart failure and normal serum creatinine [J]. Int J Cardiol, 2011, 147 (2) : 228-233.
  • 3Dimopoulos K, Diller GP, Kohsida E, et al. Prevalence, predic- tors, and prognostic value of renal dysfunction in adults with con genital heart disease[J]. Circulation,2008,117(18) :2320-2328.
  • 4Klein L, Massie BM, Leimberger JD, et al. Admission or chan ges in renal function during hospitalization for worsening heart failure predict postdischarge survival: results from the Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-CHF) [J]. Circ Heart Fail, 2008, 1 (1): 25 -33.
  • 5Lassus JP, Nieminen MS, Peuhkurinen K, et al. Markers of re- nal function and acute kidney injury in acute heart failure: defini- tions and impact on outcomes of the cardiorenal syndrome [J]. Eur Heart J, 2010, 31 (22): 2791 -2798.
  • 6Mitsnefes MM, Kathman TS, Mishra J, et al. Serum neutrophil gelatinase-associated lipocalin as a marker of renal function in children with chronic kidney disease [J]. Pediatr Nephrol, 2007, 22 (1): 101-108.
  • 7Malyszko J, Bachorzewska-Gajewska H, Sitniewska E, et al. Serum neutrophil gelatinase-associated lipoealin as a marker of re- nal function in non-diabetic patients with stage 2-4 chronic kid- ney disease[J]. RenFail, 2008, 30 (6): 625-628.
  • 8Grubb A. Non-invasive estimation of glomerular filtration rate (GFR). The Lund model: Simultaneous use of cystatin C andcreatinine-based GFR-prediction equations, clinical data and an internal quality check [J]. Scand J Clin Lab Invest, 2010, 70 (2) : 65-70.
  • 9Ronco C, Cruz DN, Ronco F. Cardiorenal syndromes [J]. Curr Opin Crit Care, 2009, 15 (5): 384-391.
  • 10Devarajan P. Emerging biomarkers of acute kidney injury [J]. Contrib Nephrol, 2007, 156: 203-212.

同被引文献126

  • 1Peter A McCullough,Aftab Ahmad.Cardiorenal syndromes[J].World Journal of Cardiology,2011,3(1):1-9. 被引量:4
  • 2Hanson ID, McCullough PA. B- type natriuretic peptide: be- yond diagnostic applications [M]. The Kidney in Heart Fail. ure, 2012: 67-77.
  • 3Angelidis C, Deftereos S, Giannopoulos G, et al. Cystatin C: an emerging biomarker in cardiovascular disease [J]. Curr Top MedChem, 2013, 13 (2) : 164-179.
  • 4Coil E, Botey A, Alvarez L, et al. Serum cystatin C as a new marker for noninvasive estimation of glomerular filtration rate and as a marker for early renal impairment [J]. Am J Kidney Dis, 2000, 36 (1) : 29-34.
  • 5Grubb A. Diagnostic value of analysis of cystatin C and protein HC in biological fluids [J]. Clin Nephrol, 1992, 38 (Suppl 1) : $20 - $27.
  • 6Kim H, Yoon HJ, Park HS, et al. Potentials of cystatin C and uric acid for predicting prognosis of heart failure [J]. Con- gest Heart Fail, 2013, 19 (3) 123-129.
  • 7Bielecka-Dabrowa A, von Haehling S, Aronow WS, et al. Heart failure biomarkers in patients with dilated cardiomyopa- thy [J]. IntJCardiol, 2013, 168 (3): 2404-2410.
  • 8P6rez-Calvo JI, Ruiz- Ruiz [J, Carrasco-Sfnchez [J, et al. Prognostic value of serum cystatin C and N-terminal pro B-type natriuretic peptide in patients with acute heart failure [J]. Eur J Intern Med, 2012, 23 (7) : 599-603.
  • 9Libby P. Inflammation in atherosclerosis[ J ]. Artefioscler Thromb Vascbiol, 2012, 32(9): 2045-2051.
  • 10Kashiwagi M, Imanishi T, Tsujioka I-I, et al. Association of mono- cyte subsets with vulnerability charactetistics of coronary plaques as assessed by 64 - slice multidetidetector computed tomography in patients with stable angina pectoris [ J ]. Atherosclerosis, 2010, 212(1): 171-176.

引证文献9

二级引证文献113

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部